Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion in cash
01:27pm, Friday, 22'nd Dec 2023
Stephanie Link and Jim Lebenthal join 'Halftime Report' to discuss Bristol Myers Squibb's latest announcement to buy Karuna Therapeutics for $14 billion.
Bristol Myers Squibb buys neurological drug developer Karuna Therapeutics in $14B deal
01:14pm, Friday, 22'nd Dec 2023
Shares of biopharmaceutical company Karuna Therapeutics skyrocketed more than 47% Friday morning after giant Bristol-Myers Squibb Co (NYSE:BMY, ETR:RM, OTC:BMYMP) announced a deal to acquire the compa
Bristol Myers (BMY) to Buy Karuna Therapeutics for $14B
12:47pm, Friday, 22'nd Dec 2023
Bristol Myers (BMY) announces a second acquisition in two months. It is set to buy Karuna Therapeutics, Inc. (KRTX) for $14 billion to strengthen its neuroscience portfolio.
Midday Movers: Karuna Jumps on Deal With Bristol Myers Squibb, Nike Falls on Sales Outlook
12:45pm, Friday, 22'nd Dec 2023
U.S. equities headed into the long holiday weekend with gains at midday, amid a broad-based rally fueled by enthusiasm over the possibility of several Fed interest rate cuts next year. The Dow, S&P 50
Bristol Myers Squibb Boosts Its Neuroscience Reach With $14 Billion Karuna Deal
12:40pm, Friday, 22'nd Dec 2023
Karuna Therapeutics (KRTX) shares skyrocketed over 46% after Bristol Myers Squibb (BMY) said it would buy the biopharmaceutical firm for $14 billion to expand its neuroscience portfolio.
Bristol-Myers Jumps on Billion-Dollar Buzz
11:07am, Friday, 22'nd Dec 2023
Bristol-Myers Squibb Co (NYSE:BMY) stock is on the rise today, up 2.8% at $52.71 at last glance, after news that the biopharmaceutical company is acquiring Karuna (KRTX) for $14 billion.
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
09:58am, Friday, 22'nd Dec 2023
Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash.
A Major Acquisition and Other News Ahead of the Holiday Weekend
09:40am, Friday, 22'nd Dec 2023
Before U.S. markets opened on Friday, the Bureau of Economic Analysis released its personal income and spending report for November.
Karuna Stock Soars On Bristol Myers' $14 Billion Takeover
09:06am, Friday, 22'nd Dec 2023
Bristol Myers Squibb announced its $14 billion acquisition of Karuna Therapeutics on Friday, sending KRTX stock into the stratosphere.
Bristol Myers to buy Karuna Therapeutics for $14B
08:40am, Friday, 22'nd Dec 2023
Karuna's crown jewel, an experimental drug called KarXT, is the product of such new insights. The drug could surpass $6 billion in yearly sales if it is approved for the various uses.
Bristol Myers to buy Karuna Therapeutics for $14 billion
07:39am, Friday, 22'nd Dec 2023
CNBC's Joe Kernen reports on the latest news.
Bristol Myers to Buys Karuna Therapeutics in $14 Billion Pharma Deal: Report
07:05am, Friday, 22'nd Dec 2023
Karuna has an experimental schizophrenia drug called KarXT up for U.S. government approval.
Bristol Myers Squibb to Present at J.P. Morgan's 42nd Annual Healthcare Conference
06:59am, Friday, 22'nd Dec 2023
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Present at J.P. Morgan's 42nd Annual Healthcare Conference.
Karuna Therapeutics' stock rockets into record territory after report Bristol Myers' $14 billion buyout agreement
06:55am, Friday, 22'nd Dec 2023
Shares of Karuna Therapeutics Inc. KRTX, +1.80% rocketed 33.8% into record territory in premarket trading Friday, after The Wall Street Journal reported that Bristol Myers Squibb Co. BMY, +0.59% has r
Bristol Myers Squibb (BMY) Rises But Trails Market: What Investors Should Know
06:47pm, Thursday, 21'st Dec 2023
In the latest trading session, Bristol Myers Squibb (BMY) closed at $51.26, marking a +0.59% move from the previous day.
